EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carcinoma In Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy

Mayumi Harada iD, Yasuhito Hagiwara iD, Takanobu Kabasawa iD, Hiraku Sato iD, Mayumi Ichikawa iD, Hiroko Akamatsu iD, Takashi Kaneko iD, Natsuko Yano iD, Ken Uematsu iD, Masanori Komatsu, Taiyo Tanae, Kenji Nemoto und 1 weitere

Cancer Reports · 2026-11 · 9 (11)

DOI: 10.1002/cnr2.70751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 05.11.2026. Verfasst von Mayumi Harada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Yamagata University Faculty of Medicine, Yamagata, Yamagata, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Carcinoma, Squamous Cell, Carcinoma in Situ. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In definitive radiotherapy for FIGO Stage I–III cervical cancer, external beam radiotherapy and/or brachytherapy are used—alone or in combination with concurrent chemotherapy depending on stage—with target delineation largely guided by clinically apparent disease. However, discontinuous carcinoma in situ (CIS) “skip lesions” within the uterine corpus are well described in cervical adenocarcinoma, whereas their presence in cervical squamous cell carcinoma (SCC) has not been systematically evaluated.

Aims

This study aimed to investigate the presence or absence of CIS skip lesions in the uterine corpus of patients with cervical SCC. Methods and Results This retrospective study included all patients who underwent total or radical hysterectomy for cervical SCC at Yamagata University Hospital between January 2013 and April 2020. Patients who underwent prior radiotherapy or preoperative chemotherapy, or had non‐squamous histological components, were excluded. Fifty patients were enrolled. Pathological examination of serially sectioned uterine specimens was conducted to identify skip lesions, defined as discontinuous CIS lesions in the uterine corpus, as confirmed by a pathologist and a radiation oncologist. Pathological evaluation showed that 29 patients (58%) had FIGO Stage I disease, 6 patients (12%) had FIGO Stage II disease, and 15 patients (30%) were classified as FIGO Stage IIIC1. Preoperative imaging studies did not identify any skip lesions in the uterine corpus. However, one patient (2%; Clopper–Pearson 95% confidence intervals: 0.05%–10.5%) presented with a histologically confirmed CIS skip lesion located in the uterine corpus, approximately 2 cm cranial to the primary tumor margin, that was undetectable on imaging. The primary tumor after biopsy measured 3 mm and was diagnosed as non‐keratinizing SCC without > 1/3 stromal invasion. Lymphovascular space invasion, parametrial invasion, and corpus invasion were not observed.

Conclusion

Although rare, CIS skip lesions in the uterine corpus can occur in patients with cervical SCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCarcinoma, Squamous CellCarcinoma in SituHumansFemaleRetrospective StudiesMiddle AgedHysterectomyNeoplasm StagingAgedAdultUterusBrachytherapy

Stichwörter der Autor:innen

radiotherapyuterine cervical neoplasmsuterus

Autor:innen und Institutionen

  • Department of Radiation Oncology, Yamagata University Faculty of Medicine, Yamagata, Yamagata, Japan.
  • Department of Pathology, Yamagata University Faculty of Medicine, Yamagata, Yamagata, Japan.

ORCID-Profile: Mayumi Harada, Yasuhito Hagiwara, Takanobu Kabasawa, Hiraku Sato, Mayumi Ichikawa, Hiroko Akamatsu, Takashi Kaneko, Natsuko Yano, Ken Uematsu, Masashi Koto

Zitieren

APA

Harada, M., Hagiwara, Y., Kabasawa, T., Sato, H., Ichikawa, M., Akamatsu, H., Kaneko, T., Yano, N., Uematsu, K., Komatsu, M., Tanae, T., Nemoto, K., & Koto, M. (2026). Carcinoma In Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy. Cancer Reports, 9(11). https://doi.org/10.1002/cnr2.70751

Vancouver

Harada M, Hagiwara Y, Kabasawa T, Sato H, Ichikawa M, Akamatsu H, et al. Carcinoma In Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy. Cancer Reports. 2026;9(11). doi:10.1002/cnr2.70751

BibTeX
@article{Harada2026,
  author = {Harada, Mayumi and Hagiwara, Yasuhito and Kabasawa, Takanobu and Sato, Hiraku and Ichikawa, Mayumi and Akamatsu, Hiroko and Kaneko, Takashi and Yano, Natsuko and Uematsu, Ken and Komatsu, Masanori and Tanae, Taiyo and Nemoto, Kenji and Koto, Masashi},
  title = {Carcinoma In Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy},
  journal = {Cancer Reports},
  year = {2026},
  volume = {9},
  number = {11},
  doi = {10.1002/cnr2.70751}
}
Kostenlos starten →